GleamWall
中文EN

CLYD BEACON TOPCO, INC.

Pharmaceutical Preparations · SEC CIK 2094256 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets28.1%
Debt / equity0.00x
Current ratio7.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q1*2026-03-312025Q32025-09-302025Q2*2025-06-302025Q1*2025-03-31
Income statement
Revenue—$0————
R&D expense$1.32M——$5.39M——
SG&A expense$5.14M——$5.17M——
Operating income-$6.46M——-$15.07M——
Interest expense$13,000——$13,000——
Pretax income-$6.13M$0—-$14.64M——
Income tax-$26,000$0—-$71,000——
Net income-$6.10M$0-$5.53M-$14.57M-$21.13M-$19.66M
EBITDA-$6.26M——-$14.97M——
EPS (basic)-1.340.00—-3.22——
EPS (diluted)-1.34——-3.22——
Weighted avg. shares (diluted)4.54M100—4.52M——
Balance sheet
Cash & equivalents$49.24M$0—$75.67M——
Current assets$52.97M—————
PP&E, net$2.88M—————
Intangibles$12.42M—————
Total assets$70.80M$0$0———
Current liabilities$6.90M—————
Total liabilities$19.90M$0$0———
Shareholders' equity$50.84M$57.13M$66.48M$84.56M$102.48M$115.59M
Shares outstanding4.54M100100———
Cash flow statement
Operating cash flow-$21.59M—————
Investing cash flow$116,000—————
Financing cash flow$0—————
Depreciation & amortization$200,000——$100,000——
Stock-based compensation$105,000——-$415,000——

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.